|7.16||-0.30 / -4.02%|
Data as of 4:00pm ET
|7.12||-0.04 / -0.56%|
The 7 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +11.73% increase from the last price of 7.16.
The current consensus among 8 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.